HEMATOPOIETIC STEM CELL TRANSPLANTATION has been used for many years to treat
various malignant and nonmalignant hematologic conditions. However, the high-dose …

The characteristics of HIV-associated ITP were documented prior to the HAART era, and the
optimal treatment beyond HAART is unknown. We performed a review of patients with HIV-…

Purpose Patients with myelodysplastic syndrome (MDS) and iron overload (IOL) often receive
iron chelation therapy (ICT); however, data on clinical outcomes are limited. We reviewed …

Many patients with primary myelofibrosis (PMF) become red blood cell (RBC) transfusion
dependent (TD), risking iron overload (IOL). Iron chelation therapy (ICT) may decrease the risk …

Monoclonal B-cell lymphocytosis (MBL) is a clonal lymphoproliferation with the immunophenotype
of chronic lymphocytic leukemia (CLL) but a B-lymphocyte count of less than 5 × 10 9 /…

Retrospective analyses suggest iron overload is associated with inferior survival (OS) in
lower risk MDS and iron chelation therapy (ICT) with improvement. However, an analysis of …

Patients (pts) with MDS and iron overload often receive iron chelation therapy (ICT), although
there are no data demonstrating that this improves clinical outcome. Pts with thalassemia …

Although many hematologic malignancies are more common in older patients, autologous
blood and marrow transplantation (ABMT) has traditionally been restricted to patients younger …

We present the case of a 60-year-old woman with long-standing primary hypothyroidism,
clinically and biochemically euthyroid on the same dose of thyroxine for years, who became …

Myelodysplastic syndrome (MDS) is characterized by ineffective hematopoiesis and risk of
progression to acute myeloid leukemia (AML). Many MDS patients (pts) require red blood cell …